Zolak
- Henry Schein (NASDAQ:HSIC) is set to acquire Florida-based Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors ((CGMs)), for an undisclosed sum.
- The development will enhance HSIC's home delivery options for patients with specialized health care needs.
- This acquisition